This site (www.nanoappsmedical.com) is now GDPR compliant and addressing the requirements of The General Data Protection Regulation (GDPR) (EU) 2016/679. This is a regulation in EU law on data protection and privacy for all individuals within the European Union and the European Economic Area. It also addresses the export of personal data outside the EU and EEA. The GDPR aims primarily to give control to citizens and residents over their personal data and to simplify the regulatory environment for international business by unifying the regulation within the EU.
From now, when you elect to comment on a post or submit personal information you will see this message: “By using this form you agree with the storage and handling of your data by this website.” The box is unchecked by default. You may elect not to agree and we will delete your personal information.
We also have the capacity to provide all your personal information stored on our server on request and will delete this information if requested by you.
The Data Controller for the purposes of GDPR is Amanda Scott.
More on the General Data Protection Regulation (GDPR) (EU) 2016/679
Why is the NA site displaying differently on my browser?
This site is fully responsive and compatible with most common operating systems and modern web browsers, such as:
Chrome
Firefox
Safari
Opera
Edge
However, please note that the retired Internet Explorer (IE) is no longer supported. Internet Explorer (IE) was officially retired and out of support as of June 15, 2022.
Pages are designed to display the same on all browsers – if you notice a problem with the display in your browser, we recommend the following to help remedy the problem:
If you have any browser plug-ins or ad blockers enabled on your browser, we recommend disabling these and returning to the site to confirm if this fixes the display issue. Ad blockers and plug-ins can change the appearance of our pages.
If the page didn’t load properly and the display of the page isn’t right, we recommend opening the same page in a private/incognito tab. If the display is correctly displayed in the private tab, we recommend clearing your browser cache.
Try viewing the page on a different browser and see if the display issue is occurring on the other browser. Unlikely.
Make sure your browser is up-to-date.
Support for updating Google Chrome
Support for updating Mozilla Firefox
News This Week
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]
MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer
Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune disease remains unknown. To make a cancer treatment from [...]
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]
Scientists Discover a Powerful New Weapon Against a Dangerous Gut Infection
The promise of an experimental treatment for C. difficile gut infections lies partly in the bacteria it leaves alive, according to early laboratory and mouse research. Broad-spectrum antibiotics can disrupt the gut’s microbial community, [...]
Your Bones May Hold a Hidden Clue to Blood Cancer Survival
For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests. In blood cancers that develop in the bone marrow, an important clue to [...]
